Steven Abramowitz, MD
Vascular Surgery · Washington, DCNPI 1821222001
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Inari Medical, Inc. at 51.5% of the total. 2025 is the largest year on record at $173,468, more than ten times the $16,769 reported in 2019. Among vascular surgery clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 646 payments — averaging $1118.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$372K
- Stryker$101K
- Boston Scientific$95K
- W. L. Gore & Associates, Inc.$59K
- Philips North America LLC$51K
- Medtronic$12K
- plus $33K from 23 others
Across 92 payments — averaging $2775.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$114K
- Medtronic$31K
- Vesper Medical$28K
- W. L. Gore & Associates, Inc.$28K
- Boston Scientific$25K
- Silk Road Medical, Inc.$17K
- plus $12K from 2 others
What the payments were for
- Consulting fees$386,15053%
- Speaking & faculty fees$210,05029%
- Grants$1,2380%
- Travel & lodging$93,40213%
- Food & beverage$23,3153%
- Education$8,3441%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 206 | $372,076 |
| Stryker | 47 | $101,196 |
| Boston Scientific | 119 | $94,679 |
| W. L. Gore & Associates, Inc. | 89 | $58,893 |
| Philips North America LLC | 59 | $51,166 |
| Medtronic(2 entities) | 37 | $11,849 |
| Argon Medical Devices, Inc. | 14 | $6,706 |
| Cook Incorporated | 4 | $6,548 |
| Cardiovascular Systems Inc. | 9 | $5,446 |
| Bard Peripheral Vascular, Inc. | 15 | $4,745 |
| Cordis US CORP. | 3 | $2,876 |
| Cardinal Health 200 LLC | 2 | $1,500 |
| Abbott | 5 | $1,354 |
| Endologix LLC | 4 | $1,226 |
| Cook Medical LLC | 15 | $985 |
| Cagent Vascular Inc | 1 | $232 |
| Surmodics, Inc. | 1 | $159 |
| Vesper Medical | 1 | $149 |
| Bolton Medical Inc | 1 | $128 |
| Penumbra, Inc. | 2 | $128 |
| Imperative Care, Inc | 1 | $116 |
| Terumo Medical Corporation | 1 | $81 |
| Smith+Nephew | 4 | $73 |
| Contego Medical, Inc | 1 | $58 |
| Tactile Systems Technology Inc | 1 | $40 |
| Venturemed Group, Inc. | 1 | $36 |
| Veryan Medical Incorporated | 1 | $19 |
| Silk Road Medical, Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$487,561
- FLOWTRIEVER CATHETER, S$376,684
- (9520) IGT Devices Undivided$34,747
- FlowTriever$34,291
- ClotTriever$34,291
- GENERAL - THERAPIES$33,371
- GORE VIABAHN Endoprosthesis$27,522
- GORE PROPATEN Vascular Graft$25,520
- GORE VIABAHN VBX Balloon Expandable Endo$17,254
- Product in Development$16,588
- GORE VIABAHN Endoprosthesis with Heparin$15,400
- VIATORR Endoprosthesis$14,960
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$13,200
- GORE-TEX Vascular Graft$13,200
- GENERAL VASCULAR INTERVENTION$12,534
- GORE-TEX Stretch Vascular Graft$9,680
- MRI Equip Undiv$8,309
- IN.PACT Admiral$8,264
- Diamondback Peripheral$6,054
- CLEANER$5,448
How this compares
$722,498 in reported general payments places this provider in the 95th percentile of 24 vascular surgery providers in District of Columbia.
See all vascular surgery providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 32 | $448 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Washington
- Misaki KiguchiWashington$187K
- Kyle ReynoldsWashington$166K
- Yang YangWashington$68K
- Danielle SalazarWashington$20K
- Salim LalaWashington$10K
- Abdullah AlfawazWashington$10K
- D'andre WilliamsWashington$9K
- Robyn MacsataWashington$5K
- Frederick BeaversWashington$5K
- Rodeen RahbarWashington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.